Clinical trials of BMS-186295 (ibesartan)
pdf
Clinical trials of BMS-186295 (ibesartan) and meta-analysis are available for the following clinical conditions:
heart failure
heart failure, angiotensin-receptor blockers, patients with preserved-LVEF heart failure
pdf
ibesartan vs placebo :
I-PRESERVE (McMurray), 2008
-
heart failure, inhibition of the renin-angiotensin system (ACEI or ARB), patients with preserved-LVEF heart failure
pdf
ibesartan vs placebo :
I-PRESERVE (McMurray), 2008
-
heart failure with preserved LVEF
heart failure with preserved LVEF , All mecanism, all type of patients
pdf
ibesartan vs placebo :
I-PRESERVE (McMurray), 2008
-
Entry terms:
Search BMS-186295 clinical trials in
Pubmed
Search BMS-186295 clinical trials in
ClinicalTrials.gov
Search BMS-186295 clinical trials in
Wikipedia
Search BMS-186295 in
drugs.com
browse_trt3b
|